GLENMEDE TRUST CO NA
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 314949
PHILADELPHIA, PA
Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$10,987,396
-$2,965,708 QoQ
Shares Held
17,621
-2.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#281
of 1,322 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. REGN ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
538,822 | $61,080,861 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
488,546 | $12,360,212 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
206,405 | $11,810,493 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
141,317 | $11,060,881 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
17,621 | $10,987,396 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,722 | $6,319,398 | |
| 7 | VCEL |
Vericel Corp
|
139,921 | $6,225,084 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
7,637 | $2,413,979 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,987,396 | 17,621 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $13,953,104 | 18,059 | Shares | Defined | 2026-05-26 | |
| 2025-12-31 | $13,939,970 | 18,060 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $25,579,762 | 40,332 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,363,332 | 37,010 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,407,306 | 6,095 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,257,361 | 6,905 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $55,670,420 | 57,840 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $72,761,935 | 82,845 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $69,752,442 | 84,758 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $59,998,807 | 83,501 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $68,610,266 | 83,501 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $63,675,099 | 88,255 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $64,070,419 | 93,008 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $59,779,793 | 101,128 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $69,655,518 | 99,733 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $56,390,946 | 89,294 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $53,678,255 | 88,698 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $49,725,698 | 89,028 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $43,217,080 | 91,341 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $51,684,072 | 106,982 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $61,112,860 | 109,173 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $70,780,532 | 113,494 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $53,681,136 | 109,937 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||